FDA Approval for Bevacizumab - National Cancer Institute
Links shared publicly online about this topic.
- 650total visits
FDA Approval for Bevacizumab - National Cancer Institute
View full resource at cancer.gov
Tags: Cancer, Breast Cancer, Colorectal Cancer Medication, Drug, Women's Health, FDA, Avastin
Most Recently Shared on December 17, 2010 at 2:17 am By:
FDA begins process to remove breast cancer indication from Avastin label http://bit.ly/f6iiRo NCI has info on Avastin http://bit.ly/eWsNNG
FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC
news-medical.net — “Genentech, a member of the Roche Group, announced today that the FDA Commissioner is revoking the approval of Avastin (bevacizumab) for the treatment of mBC in the United States.” View full resource at news-medical.net
Most Recently Shared on November 19, 2011 at 6:46 am By:
Stroke News: FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC: Genentech, a member ... http://t.co/6Wt9knP8
FDA Revokes Avastin Approval for Breast Cancer : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on November 18, 2011 at 5:25 pm By:
Bob Finn - Medical News Net Health News
The FDA is withdrawing approval of bevacizumab, marketed as Avastin, for metastatic breast cancer - http://t.co/P59yrHNo
SAFETY ALERT: FDA Revokes Approval of Avastin for Use in Breast Cancer - MPR
empr.com — “The FDA commissioner, Margaret A. Hamburg, MD, has revoked the approval of Avastin (bevacizumab; Genentech) for the treatment of breast cancer after concluding that the drug has not been shown to be safe and effective for that use.” View full resource at empr.com
Most Recently Shared on November 18, 2011 at 5:03 pm By:
FDA Revokes Avastin Indication for Breast Cancer http://t.co/vf2hgugc #oncology #breastcancer #womenshealth
FDA Commissioner announces Avastin decision
fda.gov — “FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency’s approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.” View full resource at fda.gov
Most Recently Shared on November 18, 2011 at 3:38 pm By:
P. F. Anderson Health Social Media
"women who take Avastin for metastatic #BrCa risk potentially life-threatening side effects" w/o proof of benefit http://t.co/XtqmOb0y #hcsm
Dendreon Corporation CEO Mitchell H. Gold to Receive 2011 Grace Award from Cancer Research Institute
newswise.com — “Cancer Research Institute will give the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research to Mitchell H. Gold, president and CEO of Dendreon Corporation, to celebrate the FDA approval of the company's prostate cancer vaccine, Provenge, the first FDA-approved therapeutic cancer vaccine” View full resource at newswise.com
Most Recently Shared on August 17, 2011 at 6:30 pm By:
newswise Health Communicator and Health News
Dendreon Corporation CEO Mitchell H. Gold to Receive 2011 Grace Award from Cancer Research Institute: Cancer Res... http://t.co/w6oWSLD
FDA Update on Avastin for Metastatic Breast Cancer - MPR
empr.com — “Genentech announced that during a FDA hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated, first-line HER2-negative metastatic breast cancer.” View full resource at empr.com
Most Recently Shared on June 30, 2011 at 6:25 pm By:
MPR News: FDA Update on Avastin for Metastatic Breast Cancer: Genentech announced that during a FDA hearing, the... http://bit.ly/lj1lQ3
Medical News: FDA Panel Votes to Yank Avastin's Breast Cancer Indication - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory committee has voted unanimously, 6-0, that Genentech's bevacizumab (Avastin) should no longer be approved to treat metastatic HER2-negative breast cancer.” View full resource at medpagetoday.com
Most Recently Shared on June 29, 2011 at 9:32 pm By:
FDA Panel Votes to Yank Avastin's Breast Ca Indication http://bit.ly/m948rg
Kidney cancer discovery could expand treatment options
ohsu.edu — “OHSU Knight Cancer Institute study uncovers role of gene in renal cancers that don’t respond to current therapies but could be helped by existing FDA-approved drug” View full resource at ohsu.edu
Most Recently Shared on June 8, 2011 at 5:08 pm By:
OHSU Healthcare Healthcare System
Gene found to play a role in kidney cancer. RT @sciwhat: #OHSU kidney #cancer discovery could expand treatment options: http://t.co/LqbR5BA
FDA approves new drug for advanced melanoma - 2011 Press Releases - Dana-Farber Cancer Institute
dana-farber.org — “The U.S. Food and Drug Administration approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma in more than a decade.” View full resource at dana-farber.org
Most Recently Shared on March 25, 2011 at 8:04 pm By:
The Jimmy Fund Health Organization
Today, the FDA approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. http://ow.ly/4mBsF
FDA grants Genentech hearing on Avastin use in breast cancer - ONA
oncologynurseadvisor.com — “The FDA has granted a hearing to allow Genentech the opportunity to present its views on why Avastin (bevacizumab) should remain FDA-approved for metastatic breast cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 25, 2011 at 4:16 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
FDA grants Genentech hearing on Avastin use in breast cancer http://goo.gl/fb/h27of
First FDA-Approved Cancer Treatment Vaccine Available at Roswell Park | Roswell Park Cancer Institute
roswellpark.org — “First FDA-Approved Cancer Treatment Vaccine Available at Roswell Park | Roswell Park Cancer Institute” View full resource at roswellpark.org
Most Recently Shared on February 7, 2011 at 5:37 pm By:
Provenge, 1st #FDA approved cancer treatment vaccine for advanced #prostate #cancer, being offered at RPCI http://goo.gl/zxkQ2
The Avastin Question and the Payor Community
nccn.org — “The U.S. Food and Drug Administration's (FDA) recent announcement that it is recommending removing approval for use of Avastin® (bevacizumab) for the treatment of metastatic breast cancer has generated considerable interest and strong opinions.Informed and concerned people view the decision differently:the FDA's decision is endorsed by some oncologists and patient advocacy groups and condemned by others.If the FDA affirms its decision upon appeal, then organizations that pay claims - commerc” View full resource at nccn.org
Most Recently Shared on January 24, 2011 at 4:13 pm By:
Thomas J Reid MD PhD Internist, Oncologist, Hematologist, Physician, Doctor, and PhD
Breast cancer and Avastin (bevacizumab): NCCN vs FDA. http://www.nccn.org/about/news/ebulletin/2011-01-24/avastin.asp
News - EMEA OKs Bevacizumab for Breast Cancer, But Only With Paclitaxel
docguide.com — “EMEA OKs Bevacizumab for Breast Cancer, But Only With Paclitaxel” View full resource at docguide.com
Most Recently Shared on December 16, 2010 at 7:13 pm By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
EMEA OKs Bevacizumab for Breast Cancer, But Only With Paclitaxel FDA removes the approval http://ow.ly/3qoKt
FDA begins process to remove breast cancer indication from Avastin label
fda.gov — “The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.” View full resource at fda.gov
Most Recently Shared on December 16, 2010 at 4:05 pm By:
Scott Hensley Health Organization
Here they go: FDA to take back approval of Avastin for breast cancer. http://bit.ly/dEhffW
Dysport: A New Wrinkle On Botox
sfgate.com — “Prescott, AZ (PRWEB) October 26, 2010 Southwest Skin & Cancer Institute is delighted to announce the availability of the new FDA-approved Botox alternative, Dysport. Dr. Robin Fleck of Southwest Skin & Cancer Institute,...” View full resource at sfgate.com
Most Recently Shared on October 26, 2010 at 11:45 am By:
Shalona Anuj, PhD Organic Advocate, Skin and Beauty, PhD, and Doctor
Dysport: A New Wrinkle On Botox http://bit.ly/doFDlq
Advertisement
